Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.


Updates from The Motley Fool

Latest updates on Bristol-Myers Squibb from Fool.com.


Stock Performance

BMY vs. S&P 500 | 2 Year Performance
View Interactive BMY Charts
Sponsored by

Key Data Points

Primary metrics and data points about Bristol-Myers Squibb.
Current Price: $74.81
Prev Close: $74.66
Open: $74.57
Bid: $74.51
Ask: $75.00
Day's Range: $74.22 - $75.16
52wk Range: $51.82 - $77.12
Volume: 4,861,139
Avg Vol 5,913,642
Market Cap: $124.80B
P/E (ttm): 26.76
EPS (ttm): $2.20
Div & Yield: $1.52 (2.0%)

Company Rating

What our community thinks about Bristol-Myers Squibb.
CAPS Rating 4 out of 5
 
1710 Outperform
115 Underperform
CAPS All Stars
 
462 Outperform
17 Underperform

How do you think Bristol-Myers Squibb will perform against the market?



You pick for Bristol-Myers Squibb is winning

Score: +97.74
Call: Outperform
Time Frame: Five Plus Years
Start Price: $18.24
Start Date: 3/29/2007
Gain/Loss: +$152.4%
S&P Gain/Loss: +$54.7%

Powered by Motley Fool CAPS


CEO Rating

The single most important factor in a company's success is the team that's leading the company.

Giovanni Caforio, CEO

89% Approve

Based on 126 Ratings

Powered by Glassdoor

Business Summary

Industry, sector and description for Bristol-Myers Squibb.

Bristol-Myers Squibb discovers, develops, licenses, makes, and sells pharmaceuticals, with particular success in cardiovascular treatments.

  • Exchange: NYSE
  • Sector: Healthcare
  • Industry: Drug Makers